Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study

Madely Health Headlines Commentary for October 3, 2012

Source:

Breast cancer treatment targets tumours with few side effects

Reference:

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Bitnami